Siddharth Sitaram, the Interim PFO and PAO of $DOCS, sold 2,282 shares of the company on 02-10-2026 for an estimated $63,622. We received data on the trade from a recent SEC filing. This was a sale of approximately 2.7% of their shares of this class of stock. Following this trade, they now own 81,451 shares of this class of $DOCS stock.
$DOCS Insider Trading Activity
$DOCS insiders have traded $DOCS stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $DOCS stock by insiders over the last 6 months:
- TIMOTHY S CABRAL has made 0 purchases and 2 sales selling 30,000 shares for an estimated $2,000,000.
- REGINA M. BENJAMIN has made 0 purchases and 2 sales selling 10,000 shares for an estimated $706,700.
- KIRA SCHERER WAMPLER has made 0 purchases and 4 sales selling 8,000 shares for an estimated $360,960.
- SIDDHARTH SITARAM (Interim PFO and PAO) sold 2,282 shares for an estimated $63,622
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$DOCS Hedge Fund Activity
We have seen 213 institutional investors add shares of $DOCS stock to their portfolio, and 334 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 6,613,555 shares (-75.3%) from their portfolio in Q4 2025, for an estimated $292,848,215
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 4,870,053 shares (-73.2%) from their portfolio in Q4 2025, for an estimated $215,645,946
- CITADEL ADVISORS LLC added 2,401,660 shares (+7571.2%) to their portfolio in Q4 2025, for an estimated $106,345,504
- FRANKLIN RESOURCES INC removed 1,934,514 shares (-57.6%) from their portfolio in Q4 2025, for an estimated $85,660,279
- CARMIGNAC GESTION added 1,477,798 shares (+355.9%) to their portfolio in Q4 2025, for an estimated $65,436,895
- NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO added 1,298,492 shares (+325436.6%) to their portfolio in Q4 2025, for an estimated $57,497,225
- FEDERATED HERMES, INC. added 1,213,627 shares (+3422.7%) to their portfolio in Q4 2025, for an estimated $53,739,403
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$DOCS Revenue
$DOCS had revenues of $185.1M in Q3 2026. This is an increase of 9.76% from the same period in the prior year.
You can track DOCS financials on Quiver Quantitative's DOCS stock page.
$DOCS Congressional Stock Trading
Members of Congress have traded $DOCS stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $DOCS stock by members of Congress over the last 6 months:
- REPRESENTATIVE JONATHAN L. JACKSON sold up to $50,000 on 11/06.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$DOCS Analyst Ratings
Wall Street analysts have issued reports on $DOCS in the last several months. We have seen 6 firms issue buy ratings on the stock, and 2 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 01/20/2026
- Morgan Stanley issued a "Overweight" rating on 12/15/2025
- Raymond James issued a "Strong Buy" rating on 11/21/2025
- Evercore ISI Group issued a "Outperform" rating on 11/07/2025
- B of A Securities issued a "Buy" rating on 10/27/2025
- JP Morgan issued a "Underweight" rating on 10/10/2025
- Keybanc issued a "Overweight" rating on 10/08/2025
To track analyst ratings and price targets for $DOCS, check out Quiver Quantitative's $DOCS forecast page.
$DOCS Price Targets
Multiple analysts have issued price targets for $DOCS recently. We have seen 17 analysts offer price targets for $DOCS in the last 6 months, with a median target of $45.0.
Here are some recent targets:
- Ryan Halsted from RBC Capital set a target price of $44.0 on 03/09/2026
- Alexei Gogolev from JP Morgan set a target price of $33.0 on 02/20/2026
- Jessica Tassan from Piper Sandler set a target price of $42.0 on 02/20/2026
- Glen Santangelo from Barclays set a target price of $38.0 on 02/11/2026
- Steven Valiquette from Mizuho set a target price of $34.0 on 02/10/2026
- Richard Close from Canaccord Genuity set a target price of $34.0 on 02/09/2026
- David Roman from Goldman Sachs set a target price of $34.0 on 02/09/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
